source
- FDA official says midterm elections unlikely to delay user fee reauthorization for FY 2028-2032A senior FDA official indicated that the recent midterm election results are not expected to interfere with the upcoming renewal of the agency’s user fee contracts covering fiscal years 2028 throug…
- Podcast explores how intratumoral injections may spark systemic cancer immunityIn a recent episode of BioSpace's Denatured podcast, host Jennifer C. Smith-Parker spoke with Lewis Bender, CEO of Intensity Therapeutics, and Paul-Peter Tak, president and CEO of Candel Therapeuti…